Abbott (ABT) Acquires Walk Vascular
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Abbott Labs' (ABT) Amulet Could Gain 30% Share - BofA Securities
August 31, 2021 8:46 AM EDTBofA Securities analyst Bob Hopkins reiterated a Buy rating and $133.00 price target on Abbott Labs (NYSE: ABT) after data from the European Society of Cardiology indicates that Amulet will be a major new product for the company. The analyst is modeling $230m in... More
Abbott Labs (ABT) PT Raised to $136 at BTIG
August 31, 2021 7:37 AM EDTBTIG analyst Marie Thibault raised the price target on Abbott Labs (NYSE: ABT) to $136.00 (from $126.00) while maintaining a Buy rating.... More
